Mode
Text Size
Log in / Sign up

The osteoimmune-brain axis links systemic inflammation and bone hormones to neurodegenerative pathologyImmune system may link bone health and brain disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the potential role of the osteoimmune-brain axis as a link between skeletal and neurodegenerative pathology.

This systematic review explores the osteoimmune-brain axis as a mechanism connecting skeletal and cerebral pathologies. The authors synthesize evidence regarding how the immune system acts as a central mediator through systemic inflammation, cytokine release, and bone-derived hormones to influence both bone health and neurodegeneration.

The primary finding is that these factors create a link between osteoporosis and conditions like Alzheimer's disease and dementia. While the review identifies this connection, it notes that the specific role of bone-derived factors in humans requires further validation. The authors highlight the potential for developing prevention strategies that target both skeletal and neurodegenerative diseases simultaneously.

Several limitations are noted, including uncertainty regarding whether these associations are causal or merely associative. Furthermore, the directionality of the axis—whether it is unidirectional, bidirectional, or an epiphenomenon—is not determined. These findings suggest a potential for future therapeutic targets but require more evidence to establish definitive clinical pathways.

How this fits prior evidence

This systematic review addresses a gap in understanding the underlying mechanisms connecting skeletal and neurodegenerative diseases. While prior coverage noted that amyloid-beta and tau therapies have not shown clear clinical benefit in Alzheimer's disease, this review explores an alternative pathway involving the osteoimmune-brain axis. It also complements findings on the management of ADRD by suggesting new potential targets for prevention strategies.

When we think about bone health, we often focus on fractures. However, your bones might play a much larger role in your overall health than we realized. New research highlights how the immune system acts as a bridge between our skeletal system and our brain.

This connection, known as the osteoimmune-brain axis, involves systemic inflammation and hormones produced by bone tissue. These factors can influence both bone health and neurodegenerative conditions like Alzheimer's disease and dementia. It suggests that what happens in our bones could impact how our brains function over time.

While these findings are promising for creating new prevention strategies, there is still a lot to learn. Scientists are not yet sure if these links are direct causes or just happening at the same time. Additionally, they are still investigating whether the link flows one way or both ways. More research is needed to confirm how bone-derived factors specifically affect humans.

What this means for you:
The immune system may link bone health and brain health through inflammation and hormones.

Common questions

What is the connection between bones and brain health?

The immune system acts as a central mediator between the skeletal and cerebral systems. This happens through systemic inflammation, the release of cytokines (immune signaling proteins), and hormones produced by bone tissue. These factors may link bone health to conditions like Alzheimer's disease and dementia.

Is this a proven cause for dementia?

Not yet. While researchers have found a connection between the immune system, bones, and brain health, they are still unsure if these factors directly cause disease or are simply associated with it. More research is needed to determine the exact nature of this link.

How does this change how we treat bone and brain issues?

This finding could help doctors develop new prevention strategies that target both skeletal and neurodegenerative diseases at once. However, because these are basic mechanisms and not a primary trial, you should talk to your doctor about what this means for your specific health.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Osteoporosis and cognitive dysfunction, particularly Alzheimer’s disease (AD), frequently co-occur in the elderly population, suggesting shared pathophysiological links. The emerging concept of the “osteoimmune-brain axis” provides a framework that emphasizes the immune system as the central mediator connecting skeletal and cerebral pathology. This review explores how the osteoimmune system—the dynamic interface between bone and immune interactions—influences brain function through pathways including systemic inflammation, cytokine release, and bone-derived hormones. We systematically synthesize evidence from basic mechanisms to clinical studies, with a critical appraisal of the strength and directionality of the evidence. Key questions addressed include: whether the observed associations are causal or merely associative; which bone-derived factors have human validation; and whether the axis primarily operates as a unidirectional driver, a bidirectional amplifier, or an epiphenomenon of shared aging processes. This review aims to provide a balanced theoretical foundation for future research and for developing prevention strategies targeting both skeletal and neurodegenerative diseases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.